The project also receives state aid and the first medical drugs will be put on the market at end-2024.
The new manufacturing and packaging unit initially include nine state-of-the-art technological lines for capsules and tablets, with a capacity of 100 million packages per year. The total area of the new unit covers approximately 30,000 square meters and enables a fast expansion of production lines up to 12.
STADA Arzneimittel AG Group, one of the largest pharmaceuticals companies in Germany, entered the Romanian market with a subsidiary in 1992.
The products to be manufactured at the production facility in Turda – both prescription drugs and over-the-counter drugs – will reach the European markets on which STADA group operates.
In 2020, STADA Romania had a turnover of nearly EUR21 million (including sales of WALMARK products which were integrated after acquiring the company in 2019), thus ranking among the top ten producers of generic drugs.